A novel multicomponent messenger RNA (mRNA) vaccine, mRNA-1083, demonstrated noninferiority to standard influenza and COVID-19 vaccines in adults aged 50 years or older, eliciting higher immune ...

23, 2025 — A vaccine under development has ... 2025 — Recent outbreaks of highly pathogenic avian influenza (also known as bird flu) have created a need for rapid and sensitive detection ...

The first research programs attempting to develop an inactivated influenza vaccine, outside of the USSR, were conducted in England and in the USA at about the same time. However, it was at the ...

"Although vaccines will remain the primary control measure for influenza epidemics and pandemics, antiviral drugs play a complementary role, particularly in a pandemic scenario, as well as in ...

HHS has terminated contracts with Moderna worth more than $700 million that were meant to fund the company’s development of pre-pandemic influenza vaccines, including the company’s H5 bird flu ...

Dr. Russo has concerns that the new regulations seem to have a “double standard that’s not based in science” for the COVID-19 and influenza vaccines, both of which target viruses that change ...

“Reaching the Last Patient Last Visit in this booster trial is a significant milestone for both our team and the field of influenza vaccine development,” commented Prof. Isabel Leroux ...

signed with the Biden administration — the move is being seen as a significant blow to the country’s capacity to respond to pandemic influenza. No other flu vaccine production approach can ...

Three influenza A (H5N1/bird flu ... The review indicated that strengthening surveillance, advancing vaccine strategies, expanding the use of newer vaccine technologies, coordinating international ...